Alpha Biopharma Stock
Alpha Biophama is a clinical stage biopharmaceutical company.
Sign up today and learn more about Alpha Biopharma Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Alpha Biopharma Stock
Alpha Biopharma is supported by the domestic and foreign famous funds, and committed to the clinical development of global innovator drug. The company collaborates with the large-scale international drug companies to ensure the preliminary research and development of the product is solid and reliable. By using the powerful scientific consultant and management team and developing the optimization strategy for innovative drug development, the company lay emphasis on the multi-dimensional layout: research and development/market/intellectual property protection. The specifictest operation and business development are collaborated with the international/domestic topCRO/CMO/hospital/institute, and ensure the program is rational and orderly implementation by using the company’s impeccable project management system.
Funding History
June 2018 | $37.0M |
---|---|
April 2021 | $25.0M |
Management
Founder
Liu Zhonghai
Chief Operational Officer
James Liu
Board Of Directors
William Hu
CMO
Joan CAI
Press
bioworld - Feb, 1 2023
China’s Alpha Biopharma seeks new drug status for EGFR-TKI product